Bezlotuxumab - Clostridioides difficile
You are here : Home > Formulary Search > Bezlotuxumab - Clostridioides difficile
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Not Specified
Formulary Status :
Restrictions / Comments :
Important
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed with NICE recommendation not to use bezlotoxumab to prevent recurrence of C. Difficile infection because it is not cost effective. Bezlotoxumab will be given a NON-FORMULARY traffic light status for this indication.
Documentation
PAD Profile
ChemicalSubstance :
Bezlotuxumab
Indication :
Clostridioides difficile
Group Name :
Keywords :
c.diff, antitoxin, human monoclonal antitoxin antibody
Brand Names Include :
Zinplava
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Bezlotuxumab is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Clostridioides difficile.
Committee Recommendations (1)
The Surrey Heartlands integrated care system Area Prescribing Committee (APC) agreed with NICE recommendation not to use bezlotoxumab to prevent recurrence of C. Difficile infection because it is not cost effective.
Bezlotoxumab will be given a NON-FORMULARY traffic light status for this indication.